37:
269:
396:
312:
391:
30:
286:
101:
274:
111:
71:
121:
96:
50:
15:
139:
220:
63:
46:
76:
316:
106:
280:
199:
144:
86:
385:
326:
225:
250:
235:
194:
189:
154:
54:
215:
81:
255:
240:
184:
179:
169:
164:
159:
134:
129:
230:
174:
149:
245:
91:
354:
will show the template collapsed, i.e. hidden apart from its title bar.
319:), it is hidden apart from its title bar; if not, it is fully visible.
311:, meaning that if there is another collapsible item on the page (a
19:
378:
will show the template expanded, i.e. fully visible.
357:
333:
208:
120:
62:
322:To change this template's initial visibility, the
31:
8:
140:Canrenoate potassium (potassium canrenoate)
38:
24:
16:
306:initial visibility currently defaults to
323:
72:11-Deoxycorticosterone (desoxycortone)
7:
317:table with the collapsible attribute
14:
77:11-Deoxycortisol (cortodoxone)
1:
413:
264:
92:Cortisol (hydrocortisone)
397:Endocrinology templates
112:Fludrocortisone acetate
102:Desoxycortone enanthate
122:Antimineralocorticoids
51:antimineralocorticoids
392:Drug templates by ATC
97:Desoxycortone acetate
209:Synthesis modifiers
291:Never to phase III
64:Mineralocorticoids
47:Mineralocorticoids
301:
300:
221:Aminoglutethimide
404:
377:
376:
372:
369:
366:
363:
360:
353:
352:
348:
345:
342:
339:
336:
325:
324:|state=
309:
304:This template's
40:
33:
26:
17:
412:
411:
407:
406:
405:
403:
402:
401:
382:
381:
374:
370:
367:
364:
362:Corticosteroids
361:
358:
350:
346:
343:
340:
338:Corticosteroids
337:
334:
313:navbox, sidebar
307:
302:
297:
296:
281:Clinical trials
260:
204:
116:
107:Fludrocortisone
58:
44:
12:
11:
5:
410:
408:
400:
399:
394:
384:
383:
380:
379:
355:
299:
298:
295:
294:
293:
292:
289:
278:
272:
266:
265:
262:
261:
259:
258:
253:
248:
243:
238:
233:
228:
223:
218:
212:
210:
206:
205:
203:
202:
200:Spironolactone
197:
192:
187:
182:
177:
172:
167:
162:
157:
152:
147:
145:Canrenoic acid
142:
137:
132:
126:
124:
118:
117:
115:
114:
109:
104:
99:
94:
89:
87:Corticosterone
84:
79:
74:
68:
66:
60:
59:
45:
43:
42:
35:
28:
20:
13:
10:
9:
6:
4:
3:
2:
409:
398:
395:
393:
390:
389:
387:
356:
332:
331:
330:
329:may be used:
328:
320:
318:
314:
310:
290:
288:
285:
284:
282:
279:
276:
273:
271:
268:
267:
263:
257:
254:
252:
249:
247:
244:
242:
239:
237:
234:
232:
229:
227:
226:Carbenoxolone
224:
222:
219:
217:
214:
213:
211:
207:
201:
198:
196:
193:
191:
188:
186:
183:
181:
178:
176:
173:
171:
168:
166:
163:
161:
158:
156:
153:
151:
148:
146:
143:
141:
138:
136:
133:
131:
128:
127:
125:
123:
119:
113:
110:
108:
105:
103:
100:
98:
95:
93:
90:
88:
85:
83:
80:
78:
75:
73:
70:
69:
67:
65:
61:
56:
52:
48:
41:
36:
34:
29:
27:
22:
21:
18:
321:
308:autocollapse
305:
303:
251:Osilodrostat
236:Ketoconazole
195:Progesterone
190:Nitrendipine
155:Drospirenone
23:
277:from market
216:Acetoxolone
82:Aldosterone
386:Categories
256:Trilostane
241:Metyrapone
185:Nimodipine
180:Nifedipine
170:Finerenone
165:Felodipine
160:Eplerenone
135:Benidipine
130:Amlodipine
349:collapsed
327:parameter
287:Phase III
275:Withdrawn
231:Enoxolone
175:Gestodene
150:Canrenone
373:expanded
246:Mitotane
270:WHO-EM
368:state
344:state
315:, or
49:and
55:H02
388::
375:}}
359:{{
351:}}
335:{{
283::
371:=
365:|
347:=
341:|
57:)
53:(
39:e
32:t
25:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.